Skip links

VALIDATION

Multiple studies and commercial installations demonstrate C-POLAR™ material effectively captures, inactivates, and eradicates viruses and pathogens, with up to 99.99% efficiency

Lab Validation

C-POLAR™ material eradicated 92% of Staphylococcus aureus after a 10-minute incubation period. The input of pathogens was close to 100x higher than the ISO 20743:2013 standard.

92%
ERADICATION

C-POLAR™ filters significantly improved collection efficiency and substantially reduced viable bovine coronavirus concentration by 99.3% in a single-pass, fast air-flow wind tunnel.

99.3%
CAPTURE

C-POLAR™ material eradicated >99.6% of SARS-CoV-2 within 30 minutes (98% within 5 minutes).

99.6%
ERADICATION

C-POLAR™ material eradicated >99.9% of multiple bacterial pathogens within 1 minute.

99.9%
ERADICATION

C-POLAR™ material demonstrated a viral filtration efficiency (VFE) of >99.9%.

99.9%
CAPTURE

C-POLAR™ material demonstrated a viral filtration efficiency (VFE) of >99.9%.

99.9%
CAPTURE

COMMERCIAL VALIDATION

Working in partnership with Hong Kong Metropolitan University, we installed C-POLAR™ filters in five dense foot traffic locations in Hong Kong: International Commerce Center, Central Building, K11 MUSEA, 1 Duddell Street, and China Minmetals Tower.

Testing in these areas showed C-POLAR™ filters demonstrated strong antibacterial efficiency of up to 99.9999% even after 60 days of intensive, real-world commercial use in bio-aerosol and particulate rich environments.

Our technology’s efficacy and safety has been tested and verified by leading medical and regulatory institutions in the United States, Czech Republic, Hong Kong, Finland, and United Kingdom.​